Basel Medical Group Ltd Statistics
Basel Medical Group Ltd (BMGL) Stock Statistics & Valuation Metrics
Total Valuation
Basel Medical Group Ltd has a market cap or net worth of $5.20M. The enterprise value is $14.81T.
- Market Cap
- $5.20M
- Enterprise Value
- $14.81T
Share Statistics
Basel Medical Group Ltd has 13,582,111 shares outstanding. The number of shares has decreased by 94.24% in one year.
- Shares Outstanding
- 13,582,111
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Basel Medical Group Ltd’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is 58.87%.
- Return on Equity (ROE)
- -0.15
- Return on Assets (ROA)
- -0.04
- Return on Invested Capital (ROIC)
- 58.87%
- Return on Capital Employed (ROCE)
- 1.05
- Revenue Per Employee
- 290.71K
- Profits Per Employee
- -10.11K
- Employee Count
- 74
- Asset Turnover
- 1.21
- Inventory Turnover
- 57.04
Valuation Ratios
The current PE Ratio of Basel Medical Group Ltd is -0.70. Basel Medical Group Ltd’s PEG ratio is -0.01.
- PE Ratio
- -0.70
- PS Ratio
- 0.03
- PB Ratio
- 0.11
- Price to FCF
- -0.45
- Price to Operating Cash Flow
- -0.37
- PEG Ratio
- -0.01
Income Statement
In its last fiscal year, Basel Medical Group Ltd had revenue of 21.51M and earned -748.00K in profits. Earnings per share was -0.48.
- Revenue
- 21.51M
- Gross Profit
- 8.34M
- Operating Income
- 8.33M
- Pretax Income
- -1.25M
- Net Income
- -748.00K
- EBITDA
- -439.83K
- Earnings Per Share (EPS)
- -0.48
Cash Flow
In the last 12 months, operating cash flow was -1.44M and capital expenditures -310,234, giving a free cash flow of -1.75M.
- Operating Cash Flow
- -1.44M
- Free Cash Flow
- -1.75M
- Free Cash Flow per Share
- -1.62
Dividends & Yields
Basel Medical Group Ltd pays an annual dividend of ―, resulting in a dividend yield of ―.
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -224.32%
- Earnings Yield
- -114.85%
Stock Price Statistics
- Beta
- 0.19
- 52-Week Price Change
- -97.41%
- 50-Day Moving Average
- 3.69
- 200-Day Moving Average
- 6.00
- Relative Strength Index (RSI)
- 19.85
- Average Volume (3m)
- 2.59M
Financial Position
Basel Medical Group Ltd has a current ratio of 1.23, with a Debt / Equity ratio of 190.24%.
- Current Ratio
- 1.23
- Quick Ratio
- 1.21
- Debt to Market Cap
- 1.12
- Net Debt to EBITDA
- -20.67
- Interest Coverage Ratio
- 18.12
Taxes
In its last fiscal year, Basel Medical Group Ltd paid 179.56K in taxes.
- Income Tax
- 179.56K
- Effective Tax Rate
- -0.14
Enterprise Valuation
Basel Medical Group Ltd EV to EBITDA ratio is -724.69, with an EV/FCF ratio of -5.63.
- EV to Sales
- 0.39
- EV to EBITDA
- -724.69
- EV to Free Cash Flow
- -5.63
- EV to Operating Cash Flow
- -6.84
Balance Sheet
Basel Medical Group Ltd has $529.89K in cash and marketable securities with $9.62M in debt, giving a net cash position of -$9.09M.
- Cash & Marketable Securities
- $529.89K
- Total Debt
- $9.62M
- Net Cash
- -$9.09M
- Net Cash Per Share
- -$0.67
- Tangible Book Value Per Share
- $4.19
Margins
Gross margin is 27.23%, with operating margin of 19.67%, and net profit margin of -2.40%.
- Gross Margin
- 27.23%
- Operating Margin
- 19.67%
- Pretax Margin
- -4.24%
- Net Profit Margin
- -2.40%
- EBITDA Margin
- -0.05%
- EBIT Margin
- -9.08%
Analyst Forecast
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 49.87%
- EPS Growth Forecast
- 92.79%
